Vaccinex Accounts Payable vs Short Term Debt Analysis

VCNX Stock  USD 3.60  0.11  2.96%   
Vaccinex financial indicator trend analysis is much more than just breaking down Vaccinex prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaccinex is a good investment. Please check the relationship between Vaccinex Accounts Payable and its Short Term Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaccinex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.

Accounts Payable vs Short Term Debt

Accounts Payable vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vaccinex Accounts Payable account and Short Term Debt. At this time, the significance of the direction appears to have strong relationship.
The correlation between Vaccinex's Accounts Payable and Short Term Debt is 0.61. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Vaccinex, assuming nothing else is changed. The correlation between historical values of Vaccinex's Accounts Payable and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Vaccinex are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Accounts Payable i.e., Vaccinex's Accounts Payable and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.61
Relationship DirectionPositive 
Relationship StrengthSignificant

Accounts Payable

An accounting item on the balance sheet that represents Vaccinex obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Vaccinex are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Short Term Debt

Most indicators from Vaccinex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaccinex current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaccinex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.Issuance Of Capital Stock is likely to rise to about 18.7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 6.5 M in 2024.
 2023 2024 (projected)
Depreciation And Amortization119K181K
Interest Income20.7K19.7K

Vaccinex fundamental ratios Correlations

0.630.350.35-0.17-0.60.57-0.36-0.65-0.32-0.130.66-0.36-0.29-0.040.980.220.020.58-0.480.580.680.490.170.10.6
0.630.610.76-0.84-0.440.26-0.12-0.18-0.030.60.48-0.12-0.320.330.650.29-0.280.450.230.440.140.210.64-0.431.0
0.350.610.41-0.49-0.230.16-0.060.090.040.48-0.21-0.060.090.160.330.650.020.260.10.27-0.130.080.28-0.310.62
0.350.760.41-0.81-0.280.19-0.280.22-0.130.70.43-0.28-0.260.170.360.22-0.020.290.060.350.10.180.93-0.350.76
-0.17-0.84-0.49-0.810.280.020.06-0.27-0.07-0.78-0.230.060.23-0.51-0.19-0.260.23-0.28-0.56-0.180.160.03-0.820.54-0.85
-0.6-0.44-0.23-0.280.28-0.810.850.610.790.29-0.620.850.780.15-0.54-0.54-0.51-0.990.3-0.87-0.75-0.85-0.06-0.53-0.41
0.570.260.160.190.02-0.81-0.86-0.68-0.92-0.350.51-0.86-0.82-0.670.480.620.690.79-0.650.940.770.97-0.140.750.21
-0.36-0.12-0.06-0.280.060.85-0.860.420.940.37-0.491.00.760.49-0.27-0.56-0.8-0.840.56-0.85-0.77-0.91-0.06-0.75-0.08
-0.65-0.180.090.22-0.270.61-0.680.420.490.59-0.660.420.580.35-0.66-0.04-0.1-0.610.46-0.66-0.78-0.670.45-0.52-0.14
-0.32-0.030.04-0.13-0.070.79-0.920.940.490.44-0.40.940.820.66-0.2-0.61-0.86-0.760.61-0.84-0.72-0.940.14-0.860.02
-0.130.60.480.7-0.780.29-0.350.370.590.44-0.160.370.160.38-0.080.07-0.42-0.270.56-0.17-0.6-0.380.74-0.770.63
0.660.48-0.210.43-0.23-0.620.51-0.49-0.66-0.4-0.16-0.49-0.62-0.030.72-0.2-0.050.62-0.290.60.770.560.30.190.45
-0.36-0.12-0.06-0.280.060.85-0.861.00.420.940.37-0.490.760.49-0.27-0.56-0.8-0.840.56-0.85-0.77-0.91-0.06-0.75-0.08
-0.29-0.320.09-0.260.230.78-0.820.760.580.820.16-0.620.760.45-0.25-0.38-0.47-0.760.22-0.86-0.62-0.87-0.01-0.59-0.28
-0.040.330.160.17-0.510.15-0.670.490.350.660.38-0.030.490.450.04-0.35-0.67-0.140.75-0.51-0.38-0.640.43-0.760.38
0.980.650.330.36-0.19-0.540.48-0.27-0.66-0.2-0.080.72-0.27-0.250.040.06-0.140.54-0.410.530.640.420.2-0.010.63
0.220.290.650.22-0.26-0.540.62-0.56-0.04-0.610.07-0.2-0.56-0.38-0.350.060.70.51-0.210.560.160.540.00.380.27
0.02-0.280.02-0.020.23-0.510.69-0.8-0.1-0.86-0.42-0.05-0.8-0.47-0.67-0.140.70.47-0.60.530.430.68-0.210.84-0.31
0.580.450.260.29-0.28-0.990.79-0.84-0.61-0.76-0.270.62-0.84-0.76-0.140.540.510.47-0.280.880.730.840.070.50.41
-0.480.230.10.06-0.560.3-0.650.560.460.610.56-0.290.560.220.75-0.41-0.21-0.6-0.28-0.48-0.67-0.610.27-0.690.27
0.580.440.270.35-0.18-0.870.94-0.85-0.66-0.84-0.170.6-0.85-0.86-0.510.530.560.530.88-0.480.720.960.020.580.39
0.680.14-0.130.10.16-0.750.77-0.77-0.78-0.72-0.60.77-0.77-0.62-0.380.640.160.430.73-0.670.720.78-0.10.650.1
0.490.210.080.180.03-0.850.97-0.91-0.67-0.94-0.380.56-0.91-0.87-0.640.420.540.680.84-0.610.960.78-0.130.770.15
0.170.640.280.93-0.82-0.06-0.14-0.060.450.140.740.3-0.06-0.010.430.20.0-0.210.070.270.02-0.1-0.13-0.550.66
0.1-0.43-0.31-0.350.54-0.530.75-0.75-0.52-0.86-0.770.19-0.75-0.59-0.76-0.010.380.840.5-0.690.580.650.77-0.55-0.48
0.61.00.620.76-0.85-0.410.21-0.08-0.140.020.630.45-0.08-0.280.380.630.27-0.310.410.270.390.10.150.66-0.48
Click cells to compare fundamentals

Vaccinex Account Relationship Matchups

Vaccinex fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets4.6M11.7M9.8M8.0M3.6M6.8M
Other Current Liab3.7M1.9M980K617K3.4M1.9M
Total Current Liabilities6.9M13.2M2.3M2.5M5.9M4.6M
Total Stockholder Equity(26.2M)(26.6M)7.4M5.2M(2.3M)(2.4M)
Net Tangible Assets(8.6M)(26.2M)(26.6M)7.4M8.5M8.9M
Property Plant And Equipment Net594K416K438K499K282K416.4K
Net Debt(2.8M)(1.4M)(8.2M)(5.9M)(1.3M)(1.4M)
Retained Earnings(248.6M)(277.5M)(299.9M)(319.7M)(339.9M)(356.9M)
Accounts Payable3.2M3.2M1.1M1.5M2.0M1.8M
Cash2.8M10.6M8.6M6.4M1.5M1.5M
Non Current Assets Total594K416K438K499K282K416.4K
Non Currrent Assets Other(594K)(416K)(438K)(499K)(1.0)(1.05)
Cash And Short Term Investments2.8M10.6M8.6M6.4M1.5M1.5M
Net Receivables898K157K0.0175K961K1.0M
Common Stock Shares Outstanding61.3K89.5K137.4K202.1K463.7K486.8K
Liabilities And Stockholders Equity4.6M11.7M9.8M8.0M3.6M6.8M
Non Current Liabilities Total3.7M1.1M175K247K26K24.7K
Other Current Assets336K1.1M1.6M912K853K946.6K
Other Stockholder Equity222.4M250.9M307.3M324.9M337.6M244.4M
Total Liab6.9M14.3M2.4M2.8M5.9M5.3M
Property Plant And Equipment Gross594K416K7.5M7.8M7.4M7.7M
Total Current Assets4.0M11.3M9.4M7.5M3.3M6.4M
Property Plant Equipment604K594K416K438K394.2K451.1K
Net Invested Capital(26.2M)(17.4M)7.7M5.4M(2.2M)(2.3M)
Net Working Capital(2.9M)(1.9M)7.1M4.9M(2.6M)(2.4M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaccinex Stock Analysis

When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.